Life Sciences Awards EMEA 2026: open for entries

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Life Sciences Awards EMEA 2026: open for entries

Copy of EMEA awards 2024-Shortlist Announced-1200x627.png

The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.

As ever, the Awards will recognise excellence in the life sciences legal market, showcasing the law firms, lawyers, in-house legal teams, and legal work that moved the dial in Europe, the Middle East, and Africa's life sciences industry in 2025.

The deadline for entries is December 5 2025.

ENTRY FORM

AWARDS GUIDELINES

ENTRY PORTAL

FAQs

Important Dates:

Entries Open

Entry Deadline

Shortlist Published

Gala Ceremony

October 24 2025

December 5 2025

March 2026

June 2026


All nominations must be entered through our ENTRY PORTAL. Nominations made in any other format or emailed to us will not be accepted.

For any questions about the awards or the research, please contact Life Sciences Awards editor Alex Griffiths or EMEA Research Director James Wilson.

Life Sciences Awards

The Life Sciences EMEA Awards recognise leading law firms and lawyers who specialise in the life sciences industry throughout Europe, the Middle East, and Africa.

The ceremony will celebrate outstanding legal work over the previous calendar year, showcasing firms and lawyers who are moving the dial for the life sciences industry. The award’s distinctive structure highlights firms and individuals that specialise in practice areas within life sciences.

LMG Life Sciences is a sister publication of Managing IP and works in collaboration with IFLR, Managing IP, and Benchmark Litigation to identify the best of the best from across the industry.

LEARN MORE

more from across site and SHARED ros bottom lb

More from across our site

Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
UKIPO will remain a competitive option as long as efficient service continues
A future opt-out has not been ruled out, but practitioners warn that the UK could fall behind in the AI race
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
Mike Rueckheim reunites with 12 of his former Winston & Strawn colleagues as King & Spalding continues aggressive hiring streak
As global commerce continues to expand through e-commerce platforms and digital marketplaces, protecting brands has become a growing challenge for organisations worldwide. Counterfeiting, intellectual property infringement, and online brand abuse are increasing across industries, making brand protection strategies a critical priority for businesses.
Henrik Holzapfel and Chuck Larsen of McDermott Will & Schulte explain why a Court of Appeal ruling could promote access to justice and present a growth opportunity for litigation finance
A co-partner in charge says the UK prosecution teams are a ‘vital’ part of the firm’s offering, while praising a key injunction win
Gift this article